期刊
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
卷 101, 期 2, 页码 340-348出版社
WILEY-BLACKWELL
DOI: 10.1002/jbm.a.34328
关键词
chitosan; wound healing; TGF ss 1; expression profiling; biomarkers
资金
- NIH [R01AI050875]
- Airlift Research Foundation Extremity Trauma Research Grant [109421]
- US Army MRMC [W81XWH-08-2-0120]
Burns are a significant health challenge and healing can result in scar formation. Chitosan, a derivative of chitin, has been used to promote wound healing. In this study we used gene expression profiling in a mouse model of full thickness cutaneous burn to assess the benefits of treating with a chitosan lactate dressing. Three days after wounding mice treated with chitosan showed increased expression of genes associated with formation of granulation tissue. At a later time point, seven days after wounding, genes that initially showed increased expression were now down-regulated, and there was increased expression of genes involved in remodeling suggesting that the chitosan treatment results in accelerated healing. Quantitative RT-PCR showed modulated mRNA levels for TGF beta 1 by the chitosan dressing. TGF beta 1 initially promotes healing but extended activity can result in scarring. Importantly we found that expression was elevated at day three, but decreased at day seven suggesting that chitosan treatment will not result in scar formation, and may even be beneficial in preventing scar formation. Additionally, the biphasic regulation of expression of TGF beta 1 could be a powerful biomarker for future studies of the wound-healing potential of chitosan based and other treatments for burn wounds. (c) 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2013.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据